Robert Gray

CIK: 0001788480

Transaction Breakdown

Open Market Buys (P)1 (33.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

NVNO

enVVeno Medical Corp

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

NVNO
enVVeno Medical Corp
Dec 11, 2025
Award(A)
Stock Options
Direct
135.9K shares-
NVNO
enVVeno Medical Corp
Dec 31, 2024
Purchase(P)
Direct
3.5K shares at avg. $2.94$10K
NVNO
enVVeno Medical Corp
Dec 18, 2024
Award(A)
Stock Options
Direct
19.8K shares-

		Type	Shares	Price		Ownership
Dec 11, 2025	NVNO enVVeno Medical Corp	Award(A) Stock Options	135,883	-	-	Direct
Dec 31, 2024	NVNO enVVeno Medical Corp	Purchase(P)	3,500	$2.94	$10,290	Direct
Dec 18, 2024	NVNO enVVeno Medical Corp	Award(A) Stock Options	19,752	-	-	Direct

1-3 of 3 transactions

About Gray Robert

Gray Robert (SEC CIK 0001788480) files insider reports with the SEC as Director of enVVeno Medical Corp (NVNO).

Signal8 holds 3 ownership filings by Gray Robert, all Form 4s, filed between Dec 20, 2024 and Dec 15, 2025. Those filings report 3 transactions, from Dec 18, 2024 to Dec 11, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Gray Robert's filings is in IRVINE, CA.

Recent filings by Gray Robert

Dec 11, 2025: Grant or award of NVNO derivative securities (Form 4, code A).
Dec 31, 2024: Open-market purchase of NVNO shares (Form 4, code P).
Dec 18, 2024: Grant or award of NVNO derivative securities (Form 4, code A).

Other insiders filing for enVVeno Medical Corp (NVNO)

Duhay Francis, Director
BERMAN ROBERT ANDREW, Chief Executive Officer
Alavi Hamed, Chief Technology Officer
Glickman Marc H., SVP & Chief Medical Officer
Jenusaitis Matthew, Director
Shrivastava Sanjay, Director

How to read Form 4 transaction codes